SEC
|
Avagliano Mark
|
Chief Business Officer
|
|
-2.6K
|
$2.51
|
-$6.62K
|
|
SEC
|
Bailey John E. (Jack) Jr.
|
President and CEO
|
|
-7.7K
|
$2.51
|
-$19.23K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
-2.5K
|
$2.51
|
-$6.21K
|
|
SEC
|
MURDOCK TERRY L
|
Chief Operating Officer
|
|
-2.5K
|
$2.51
|
-$6.21K
|
|
SEC
|
Perry Andrew
|
Chief Commercial Officer
|
|
-1.3K
|
$2.51
|
-$3.36K
|
|
SEC
|
Umstead John W. V
|
Chief Financial Officer
|
|
-527
|
$2.51
|
-$1.32K
|
|
SEC
|
Thomas Monica R.
|
Chief Legal & People Officer
|
|
-5.8K
|
$4.27
|
-$24.88K
|
|
SEC
|
Avagliano Mark
|
Chief Business Officer
|
|
-8.2K
|
$4.79
|
-$39.04K
|
|
SEC
|
Bailey John E. (Jack) Jr.
|
President and CEO
|
|
-37K
|
$4.79
|
-$178.47K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
-8.2K
|
$4.79
|
-$39.04K
|
|
SEC
|
MURDOCK TERRY L
|
Chief Operating Officer
|
|
-8.2K
|
$4.79
|
-$39.04K
|
|
SEC
|
Umstead John W. V
|
Chief Financial Officer
|
|
-8.2K
|
$4.79
|
-$39.04K
|
|
SEC
|
Umstead John W. V
|
Chief Financial Officer
|
|
-6.5K
|
$3.02
|
-$19.77K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
-29K
|
$4.62
|
-$132.13K
|
|
SEC
|
Avagliano Mark
|
Chief Business Officer
|
|
-4.1K
|
$3.09
|
-$12.61K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
-3.7K
|
$3.08
|
-$11.52K
|
|
SEC
|
MURDOCK TERRY L
|
Chief Operating Officer
|
|
-3.7K
|
$3.08
|
-$11.52K
|
|
SEC
|
Umstead John W. V
|
Chief Financial Officer
|
|
-743
|
$3.09
|
-$2.30K
|
|
SEC
|
Bailey John E. (Jack) Jr.
|
President and CEO
|
|
-12K
|
$3.12
|
-$36.46K
|
|
SEC
|
Perry Andrew
|
Chief Commercial Officer
|
|
-2.4K
|
$3.12
|
-$7.53K
|
|
SEC
|
Bailey John E. (Jack) Jr.
|
President and CEO
|
|
-33K
|
$3.27
|
-$107.85K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
-34K
|
$3.41
|
-$115.39K
|
|
SEC
|
Velleca Mark A.
|
N/A
|
|
-60K
|
$2.00
|
-$120.00K
|
|
SEC
|
Bailey John E. (Jack) Jr.
|
President and CEO
|
|
-2.7K
|
$2.45
|
-$6.66K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
-1.4K
|
$2.45
|
-$3.33K
|
|
SEC
|
Perry Andrew
|
Chief Commercial Officer
|
|
-355
|
$2.45
|
-$869.75
|
|
SEC
|
Hanson James S.
|
General Counsel
|
|
+16K
|
$0.65
|
+$10.10K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
+16K
|
$0.65
|
+$10.10K
|
|
SEC
|
Moses Jennifer K.
|
CFO
|
|
+20K
|
$0.53
|
+$10.56K
|
|
SEC
|
MURDOCK TERRY L
|
Chief Operating Officer
|
|
+16K
|
$0.65
|
+$10.10K
|
|
SEC
|
Bailey John E. (Jack) Jr.
|
President and CEO
|
|
+43K
|
$1.85
|
+$79.69K
|
|
SEC
|
Perry Andrew
|
Chief Commercial Officer
|
|
+15K
|
$0.27
|
+$4.13K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
-648
|
$5.17
|
-$3.35K
|
|
SEC
|
MURDOCK TERRY L
|
Chief Operating Officer
|
|
-648
|
$5.17
|
-$3.35K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
+10K
|
$0.30
|
+$3.00K
|
|
SEC
|
Moses Jennifer K.
|
CFO
|
|
+2.3K
|
$4.11
|
+$9.59K
|
|
SEC
|
Avagliano Mark
|
Chief Business Officer
|
|
+11K
|
$1.14
|
+$12.03K
|
|
SEC
|
Hanson James S.
|
General Counsel
|
|
+11K
|
$1.14
|
+$12.03K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
+11K
|
$1.14
|
+$12.03K
|
|
SEC
|
Moses Jennifer K.
|
CFO
|
|
+11K
|
$1.14
|
+$12.03K
|
|
SEC
|
MURDOCK TERRY L
|
Chief Operating Officer
|
|
+11K
|
$1.14
|
+$12.03K
|
|
SEC
|
Bailey John E. (Jack) Jr.
|
President and CEO
|
|
+12K
|
$4.43
|
+$52.61K
|
|
SEC
|
Velleca Mark A.
|
N/A
|
|
+40K
|
$0.39
|
+$15.60K
|
|
SEC
|
Velleca Mark A.
|
N/A
|
|
-30K
|
$19.01
|
-$570.30K
|
|
SEC
|
Velleca Mark A.
|
N/A
|
|
+20K
|
$0.39
|
+$7.80K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
+10K
|
$0.30
|
+$3.00K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
-15K
|
$22.07
|
-$331.05K
|
|
SEC
|
Velleca Mark A.
|
N/A
|
|
-30K
|
$24.46
|
-$733.80K
|
|
SEC
|
Moses Jennifer K.
|
CFO
|
|
+3K
|
$3.72
|
+$11.16K
|
|
SEC
|
Malik Rajesh
|
Chief Medical Officer
|
|
+3.1K
|
$0.39
|
+$1.21K
|
|
SEC
|
Velleca Mark A.
|
N/A
|
|
+4K
|
$11.62
|
+$46.48K
|
|
SEC
|
RUDNICK SETH
|
N/A
|
|
-924
|
$20.10
|
-$18.57K
|
|
SEC
|
RUDNICK SETH
|
N/A
|
|
-32K
|
$20.27
|
-$650.50K
|
|
SEC
|
RUDNICK SETH
|
N/A
|
|
-19K
|
$20.22
|
-$393.89K
|
|
SEC
|
RUDNICK SETH
|
N/A
|
|
-520
|
$20.09
|
-$10.45K
|
|
SEC
|
MUIR GLENN P
|
N/A
|
|
+50K
|
$13.50
|
+$675.00K
|
|
SEC
|
Bailey John E. (Jack) Jr.
|
N/A
|
|
+8K
|
$12.80
|
+$102.40K
|
|
SEC
|
Hanson James S.
|
General Counsel
|
|
+1K
|
$14.95
|
+$14.95K
|
|
SEC
|
Malik Rajesh
|
Ch. Medical Officer & SVP R&D
|
|
+5K
|
$0.39
|
+$1.95K
|
|
SEC
|
Moses Jennifer K.
|
CFO
|
|
+1K
|
$3.72
|
+$3.72K
|
|
SEC
|
Velleca Mark A.
|
President and CEO
|
|
+6K
|
$0.39
|
+$2.34K
|
|
SEC
|
Moses Jennifer K.
|
CFO
|
|
+2K
|
$3.72
|
+$7.44K
|
|
SEC
|
Malik Rajesh
|
Ch. Medical Officer & SVP R&D
|
|
+7K
|
$0.39
|
+$2.73K
|
|
SEC
|
Moses Jennifer K.
|
VP of Finance
|
|
+2K
|
$3.72
|
+$7.44K
|
|
SEC
|
Velleca Mark A.
|
President and CEO
|
|
+9K
|
$0.39
|
+$3.51K
|
|
SEC
|
Strum Jay
|
Chief Scientific Officer
|
|
+80K
|
$0.35
|
+$27.94K
|
|
SEC
|
Hanson James S.
|
General Counsel
|
|
+1K
|
$18.25
|
+$18.25K
|
|
SEC
|
Schwalm Cynthia
|
N/A
|
|
+1.4K
|
$18.45
|
+$26.20K
|
|
SEC
|
Malik Rajesh
|
Ch. Medical Officer & SVP R&D
|
|
-3.8K
|
$30.00
|
-$113.28K
|
|
SEC
|
DEMAREE JOHN
|
Chief Commercial Officer
|
|
+1K
|
$33.15
|
+$33.15K
|
|
SEC
|
Hanson James S.
|
General Counsel
|
|
+1K
|
$32.51
|
+$32.51K
|
|
SEC
|
Moses Jennifer K.
|
VP of Finance & Admin
|
|
+2K
|
$9.49
|
+$18.98K
|
|
SEC
|
Malik Rajesh
|
Ch. Medical Officer & SVP R&D
|
|
-3.8K
|
$41.71
|
-$157.50K
|
|
SEC
|
Velleca Mark A.
|
President and CEO
|
|
-5K
|
$41.53
|
-$207.65K
|
|
SEC
|
Moses Jennifer K.
|
VP of Finance & Admin
|
|
-750
|
$44.52
|
-$33.39K
|
|
SEC
|
Strum Jay
|
Chief Scientific Officer
|
|
+850
|
$0.30
|
+$255.00
|
|
SEC
|
Moses Jennifer K.
|
VP of Finance & Admin
|
|
+2K
|
$14.98
|
+$29.96K
|
|
SEC
|
Strum Jay
|
Chief Scientific Officer
|
|
-10K
|
$59.60
|
-$596.00K
|
|
SEC
|
Velleca Mark A.
|
President and CEO
|
|
-1K
|
$20.81
|
-$20.81K
|
|
SEC
|
Malik Rajesh
|
Ch. Medical Officer & SVP R&D
|
|
+4.2K
|
$0.39
|
+$1.64K
|
|
SEC
|
Velleca Mark A.
|
President and CEO
|
|
+10K
|
$0.39
|
+$3.90K
|
|
SEC
|
Reed Douglas MD
|
N/A
|
|
-800K
|
$48.00
|
-$38.40M
|
|
SEC
|
Reed Douglas MD
|
N/A
|
|
-38K
|
$51.11
|
-$1.92M
|
|
SEC
|
Malik Rajesh
|
Ch. Medical Officer & SVP R&D
|
|
+4.2K
|
$0.39
|
+$1.64K
|
|
SEC
|
Velleca Mark A.
|
President and CEO
|
|
-7.5K
|
$20.01
|
-$150.08K
|
|
SEC
|
MedImmune Ventures, Inc.
|
N/A
|
|
-200K
|
$19.75
|
-$3.95M
|
|
SEC
|
MedImmune Ventures, Inc.
|
N/A
|
|
-134K
|
$19.75
|
-$2.64M
|
|
SEC
|
MedImmune Ventures, Inc.
|
N/A
|
|
-200K
|
$20.01
|
-$4.00M
|
|
SEC
|
ESHELMAN FREDRIC N
|
N/A
|
|
+250K
|
$19.73
|
+$4.93M
|
|
SEC
|
ESHELMAN FREDRIC N
|
N/A
|
|
+3.4M
|
$15.00
|
+$51.59M
|
|
SEC
|
Eshelman Ventures, LLC
|
N/A
|
|
+3.4M
|
$15.00
|
+$51.59M
|
|
SEC
|
Kolchinsky Peter
|
N/A
|
|
+2.7M
|
$15.00
|
+$40.26M
|
|
SEC
|
MedImmune Ventures, Inc.
|
N/A
|
|
+3.5M
|
$15.00
|
+$52.27M
|
|
SEC
|
MUIR GLENN P
|
N/A
|
|
+121K
|
$15.00
|
+$1.81M
|
|
SEC
|
Reed Douglas MD
|
N/A
|
|
+4.2M
|
$15.00
|
+$62.61M
|
|